Presentation
Related topics:
Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Clinical
Availability: FREE
Speaker
Amanda Pulfer
Strategic Director
OPEN VIE
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
- Leading insights on the role of RWE in regulatory decision-making
- Lessons from inside the FDA's RCT-DUPLICATE demonstration
- Implications for Medical Affairs planning and key decision makers
Speaker
Jeremy Rassen
President and Chief Science Officer
Aetion, USA
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker
Tessa Pugh
CEO
PharmaReview, UK
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speakers
William Soliman
President & CEO
Accreditation Council for Medical Affairs
Eric Bouilloux
Associate VP, Scientific Affairs - Operations
Accord Healthcare, UK
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
- Identify the logistical and resource barriers to domestic and global stakeholder engagement & insight retention
- Learn about innovative communication solutions that leading organizations utilize to overcome these challenges and drive value-added insight development.
- Discuss how to use these solutions to deliver improved engagement outcomes while maintaining regulatory compliance
Speaker
Andy Bowman
Managing Director
Within3
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker
Jessica Ingram
Managing Director
OPEN Health Medical Communications
Presentation
Related topics:
Availability: FREE
- Addressees & Purposes
- Challenges in compiling the right data
- Current solutions and suitable data sources
- Outlook to the future: a new claims data treasure through the digital care act?
Speaker
Michael Weisser
CEO
AIM Gmbh (Assessment-in-Medicine)
Presentation
Related topics:
Availability: FREE
The principles of market access differ greatly from traditional 4 P product price place promotion Marketing. The winning combination of clear demonstration of Patient, Provider Payer and Product benefits (Optimizing price but maximising the availability to patients who need the technology most) to HTA’s leads to faster adoption meaning patients receive great technologies sooner.
Speaker
Michael Branagan-Harris
CEO
Device Access UK
Presentation
Related topics:
Availability: FREE
- Identifying decision-makers’ needs
- Assessing the relevant data to support claims
- Building a concrete value story
- Next steps: Teams, not tools, demonstrate value
Speaker
Richard Charter
Director Value-Based Healthcare
ValueConnected
Presentation
Related topics:
Availability: FREE
While evidence requirements have changed under the new European framework for CE arking, the movement towards pan-European Health Technology Assessment also has gained traction, prompting greater conformity of HTA evidence requirements and "transplantation" of evidence reviews across geographies within the European Union. Companies can expect CE Mark requirements to be more aligned with the demands of HTA bodies for reimbursement, but the challenges for medical device firms are greater, as local HTA bodies may be commissioned to implement assessments that have a pan-European impact.
Speaker
Stephen Hull
Principal and Founder
Hull Associates, USA
Presentation
Related topics:
MedTech, Market Access & HEOR, Commercial
Availability: FREE
Value Based Healthcare requires a new way of thinking. It requires fluently navigating clinical outcomes and economic costing. This presentation will cover WHY VBHC is necessary, HOW Value based procurement enables VBHC, WHO needs to be involved in the collaborative dialogue, and WHAT the role of VBAPs are in overcoming clinical and economic uncertainty to drive medtech adoption.
Speaker
Ernesto M. Nogueira
CEO and Founder
ValueConnected
Presentation
Related topics:
MedTech, Commercial, Digital & Technology
Availability: FREE
- Understand how to turn the C-Suite into digital advocates
- Experience how the first movers in medtech have proven digital technology ROI
- See how you can use your digital investments to enable better customer experiences for payers and HCPs
- Explore how digital technology supports a key account strategy
- Learn how to get it right: start small and scale fast
Speaker
Nicolai Nygaard Worsøe
Client Director
Agnitio
Presentation
Related topics:
MedTech, Commercial
Availability: FREE
- ‘The milkman model’ evolution(?) in the MedTech industry
- Fundamental barriers to commercial model innovation in the MedTech industry
- The role of customer insights in breaking the evolution barriers
- Key learnings for the MedTech industry
Speakers
Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands
Jami Krueger
Global Insights Director
Align Technology
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
- Meeting the needs of health system stakeholders demanding both clinical and real-world evidence to inform decisions regarding product use and reimbursement
- Case study: The benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs
Speaker
Mike D’Ambrosio
Senior Project Director, Real World & Late Phase
Syneos Health, UK
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
- Identify the logistical and resource barriers to domestic and global KOL engagement
- Which solutions can enable Pharma & MedTech to better engage & generate valuable insights from KOLs & External Experts
- Improving KOL engagement outcomes while maintaining regulatory compliance
Speakers
Pauline De Mari
Vaccines Innovative Medical Engagement Lead
Sanofi
Andy Bowman
Managing Director
Within3
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement
Availability: FREE
Speaker
Louise Picken
Senior Scientific Director
Complete HealthVizion
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
- Evolution in the strategic role of Medical Affairs
- Insight management as a core capability
- Optimising the sourcing and use of insights
Speaker
Helen Blomfield
Consultant
Kinapse (A Syneos Company)
Presentation
Related topics:
Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Commercial
Availability: FREE
- How can Medical Affairs lead the charge to develop an organizationally-aligned narrative and drive scientific positioning within the medical landscape?
- How do we ensure cross-functional alignment on holistic evidence generation from (early) clinical development to post-approval lifecycle management?
- How do we ensure all Medical Affairs activities are clearly driving value?
Speaker
Timo Schwemer
Director, Consulting
Syneos Health
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
- Identify the logistical and resource barriers to domestic and global stakeholder engagement & insight retention
- Learn about innovative communication solutions that leading organizations utilize to overcome these challenges and drive value-added insight development.
- Discuss how to use these solutions to deliver improved engagement outcomes while maintaining regulatory compliance
Speaker
Amy Pinelli
Regional Vice President, Business Partnerships
Within3
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
As the life sciences industry shifts its understanding of customers to help meet organizational goals, account management can help power strategic partnerships in an increasingly complex healthcare landscape. The session audience will learn:
- Key developmental stages of a multi-dimensional account management model, the specific value drivers in each stage, and how to effectively leverage current and emerging data
- How to build a strategic key account management (KAM) program that enables effective planning, visualization, and execution across accounts and teams
- How to leverage data to drive collaboration among stakeholders.
Speaker
Robert Groebel
Vice President - Global Medical/KAM Strategy
Veeva Systems
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
- Historically, product development has largely been disengaged from commercialization
- However, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
- This presentation will describe and illustrate with a case study the benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs
Speaker
David Thompson
Senior Vice President Real World and Late Phase
Syneos Health
Presentation
Related topics:
Pharmaceutical/Biotech, Nordic, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker
Thomas Fast
Project Manager & RWE Expert
Institute of Applied Economics & Health Research (ApHER)
Presentation
Related topics:
Availability: FREE
- Target Audience
- Why this course?
- Why is sales a life skill?
- Course Outcomes
- What will you achieve?
Speakers
Geoff Cable
CEO & co-Founder
NextLevel Life Sciences
Luke Rogers
CEO & co-Founder
NextLevel Life Sciences
Presentation
Related topics:
MedTech, Commercial, Regulations & Ethics
Availability: FREE
- Beyond Marketing: Getting to the right product claims and getting the product claims right.
- Beyond MDR: How to turn novel regulatory requirements into differentiating opportunities?
- Beyond Product Launch: Clinical vs. economic claims? The right choices for effective Market Access.
Speaker
Claus Schaffrath
Managing Director, MD squared
Consultant, Cetas Healthcare
The Netherlands
Presentation
Related topics:
MedTech, Commercial, Digital & Technology, Capabilities & Effectiveness
Availability: FREE
Industry consolidation, competition and product innovation are driving the medical device industry to constantly evolve if they are to keep up with market and patient needs. This poses a great challenge, but also a great opportunity, to learning and enablement leaders who strive to successfully support sales, medical affairs and distribution partners to develop strong customer relationships and deliver the best technology solutions for the end patient or consumer. In this talk, you will learn:
- How learning leaders are driving behaviour change that improves job performance
- New ways to scale and measure the impact of enablement initiatives on commercial goals
- Case studies of how medical device providers and other leading enterprises are achieving commercial agility
- How to apply best practice microlearning to commercial, medical affairs and channel enablement
Speaker
Michael Connolly
Enterprise Account Director, EMEA
Qstream, UK
Presentation
Related topics:
MedTech, Commercial, Digital & Technology
Availability: FREE
- Experience how the first movers in medtech have proven digital technology ROI
- See how you can use your digital investments to enable better customer experiences for payers and HCPs
- Explore how digital technology supports a key account strategy
- Learn how to get it right: start small and scale fast
- Get C-level backing by showing measurable results
Speaker
Luis Rodriguez
Global Client Director
Agnitio, Denmark
Presentation
Related topics:
MedTech, Commercial, Capabilities & Effectiveness
Availability: FREE
- Overview of ‘Solutions’ offerings
- Performance of integrated health solutions so far
- Industry-wide learnings and future trends
- Common Pit-falls and Challenges
- Overcoming the challenges in implementing ‘solutions’ strategy
Speakers
Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands
Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, USA
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
Speakers
Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK
Charlotte Moseley
Global Head
Complete HealthVizion, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker
Gavin Kenny
Account Director
OPEN Health Medical Communications, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker
Angela Rylands
Principal Consultant Patient Centred Outcomes
Open Health, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
- Historically, product development has largely been disengaged from commercialization
- However, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
- This presentation will describe and illustrate with a case study the benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs
Speaker
Erwin De Cock
Principal, Real-World & Late Phase
Syneos Health
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
- Decision-making to create simplicity
- Implementation of strategic frameworks
- Organizational culture and performance in Medical Affairs
Speaker
Gemma Pfister
Executive
Vynamic, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
Case Study: How outsourcing can unburden your team to focus on value-adding relationships
Speaker
Tessa Pugh
Director
PharmaReview, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
- Identify the logistical and resource barriers to domestic and global stakeholder engagement
- Learn about innovative communication solutions that leading organizations utilize to overcome these challenges
- Discuss how to use these solutions to deliver improved engagement outcomes while maintaining regulatory compliance
Speaker
Peter Gannon
Senior Vice President, Business Partnerships
Within3
Presentation
Related topics:
Discovery & R&D Innovation, Digital & Technology
Availability: FREE
The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. However, there are opportunities to reverse this trend, which will require new ways of working and a complete digital transformation to unlock R&D productivity and deliver the next generation of scientific breakthroughs.
Speaker
Mark Steedman
Research Manager
Deloitte UK Centre for Health Solutions
Presentation
Related topics:
IT & Big Data
Availability: FREE
- Cloud genomic data sets are approaching a total of 250 Petabytes representing an unprecedented resource for research and clinical applications
- Extreme-scale cloud-based compute and tools are required to federate and utilize the emerging global resource, conforming to localized compliance requirements
- A rapid evolution in data resource architecture and applicable tools is required, with an important role to be played by Artificial Intelligence
Speaker
Richard Daly
CEO
DNAnexus, Inc., USA
Presentation
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Regulations & Ethics
Availability: FREE
Regulatory approval has traditionally been the main hurdle for developers trying to bring needed new drugs to patients. However, today, expedited regulatory pathways enable drugs for severe diseases to receive approval with less data whilst payers, in the face of budgetary pressures, are demanding more data. Thus, the gap has widened between what evidence regulators require and what payers desire.
Strategies to bridge this gap and translate regulatory approval into optimal reimbursement are becoming increasingly key to ensure the commercial success of innovative new products, which will be the focus of this presentation and will include:
- Making RCTs more payer relevant.
- Real world evidence utilization.
- Innovative pricing models.
- Early scientific advice.
Speakers
Janice Haigh
VP Pricing & Market Access
Parexel Access Consulting
Richard Macaulay
Principal Consultant
Parexel
Presentation
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE
- The key go-to-market opportunities and challenges for autologous gene and cell therapies - from the regulatory (‘benefit/risk’), market access (funding and pricing) and commercialisation (treatment delivery) perspectives
- The value of integrated, cross-functional decision-making, strategies and tactics to overcome go-to-market hurdles for autologous gene and cell therapies
- The implications for Pharma around organisational structure, organisational processes and capabilities
Speaker
Akshay Kumar
Principal Consultant
Huron Consulting Group, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Canada
Availability: FREE
- Impact of PMPRB proposed price reforms – new reference countries, HTA to set price thresholds, risk based assessments.
- pan Canadian Pharmaceutical Alliance (pCPA) – more structure, guidelines, for negotiating public payer listing agreements / access schemes.
- Implementation of National Pharmacare – proposals for “public only” national pharmacare program are again being considered seriously by Federal advisory committee.
- Insurers for private drug plans seek to maintain market but gain access to pCPA rebates.
- Outlook and implications for Canadian pricing and market access.
Speaker
Dylan Lamb-Palmer
Manager, Pricing and Data Analytics
PDCI Market Access, Canada
Presentation
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE
- How a product's characteristics or attributes contribute to both individual willingness to pay and "value" from different perspectives (e.g., stakeholder, society).
- The various methodologies through which attribute value can be assessed.
- A real-world case study of how decision-analytic modeling helped a leading company establish the value of a unique product attribute, and by so doing justify higher tender pricing in a key EU market.
Speaker
Mason Russell
Vice President, Strategic Consulting (Life Sciences)
IBM Watson Health , USA
Presentation
Related topics:
MedTech, Market Access & HEOR
Availability: FREE
- What is the role of market access in economic selling?
- The challenge of quantifying value.
- Building effective tools and training methods.
- Partnering with commercial teams.
- Case studies: Selling value in the UK and Germany.
Speaker
Ernesto M. Nogueira
Managing Director
ValueConnected
Presentation
Related topics:
MedTech, Market Access & HEOR
Availability: FREE
- Are traditional reimbursement systems adequate for innovation?
- Rewarding value, not only cost or evidence
- Innovative Payment Mechanisms in Europe
- Implications to Market Access Strategy
Speaker
Ben Modley
Director of European Operations
ValueConnected
Presentation
Related topics:
MedTech, Market Access & HEOR
Availability: FREE
- Identifying decision-makers’ needs
- Assessing the relevant data to support claims
- Building a concrete value story
- Next steps: Teams, not tools, demonstrate value
Speaker
Ernesto M. Nogueira
Managing Director
ValueConnected
Presentation
Related topics:
MedTech, Market Access & HEOR
Availability: FREE
The progression towards a pan-European HTA framework will pose new challenges to device and diagnostics companies as they contend with a heightened focus on higher quality evidence, with unchanged local decisionmaking around reimbursement. This session will explore concepts in evidence development for medical technologies, and how European payment systems have evolved to demand greater clinical and economic value than ever before.
Speaker
Stephen Hull
Principal and Founder
Hull Associates, USA
Presentation
Related topics:
MedTech, Market Access & HEOR
Availability: FREE
- Technology disruption: Non-healthcare players entering the market. Impact on our business model?
- Technology-enabled care delivery: How do data, analytics and machine learning offer opportunities to address emerging payer and provider needs?
- Reimaging the future state of med tech innovation: What kind of capabilities do we need to capture these new sources of value?
- The case of diabetes management: Data at the center.
Speaker
Sotiris Rompas
Director, Life Sciences
Huron Consulting, UK
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
- Defining pathway disruption
- Challenges of value measurement
- Market Access and Real World Evidence solutions to overcome challenges
Speaker
Amanda Pulfer
Managing Director
PH Associates
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
- Areas of opportunity
- Main hurdles
- Elegant method to answer new questions with existing data
- Methodology – bias and confounding
- Opportunity for strategic partnership
- Value for money
Speaker
Torkild Stenbock
General Manager
LINK Medical Research, Norway
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Patient-Centricity & Care
Availability: FREE
- Existing data sources as unique tools for study program pre-evaluation
- Unique patient centric methodology to answer new questions
- Patient centric, active surveillance methodology as a tool for in-depth validation of special medial outcome events
- Classical non-interventional study approaches to complement the holistic view on the patient
Speaker
Marc Pignot
Director Real World Research Consulting
Kantar Health, Germany
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
- Outlining how, historically, product development has largely been disengaged from commercialization
- Exploring how, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
- Describing and illustrating with a case study the benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory and commercial needs
Speaker
Erwin De Cock
Principal, Real-World & Late Phase
Syneos Health
Presentation
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology, Medical Science Liaison
Availability: FREE
Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.
Speaker
Pamela Peters
Szenior Director, Medical Affairs Strategic Solutions
Medscape